PAPAX Mutual Fund

PAPAX Mutual Fund

NAV$9.93
See how much of PAPAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jan 31, 2026

Net Assets
$117.85
Expense Ratio
2.00%
Dividend Yield (Current)
6.03%
Holdings
36
Inception Date
Sep 23, 2022
Fund Family
Princeton Adaptive Premium Fund
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Quarterly

Performance

YTD+1.97%
1 Year+4.67%
3 Year+4.23%

Asset Allocation

Bonds: 97.06%
Cash: 3.01%
See how much of PAPAX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
-B 2/3/26 Govt10.14%
-Treasury Bill Apr 14, 20268.95%
-Treasury Bill Feb 24, 2026 2026-02-248.71%
-Treasury Bill 0% Feb 10, 20268.44%
-Treasury Bill 0% Mar 03, 20268.42%
Top 10 Concentration: 76.05%Report Date: Jan 31, 2026
Download all 36 holdings for PAPAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
6.03%
Frequency
Quarterly

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

PAPAX Mutual Fund Overview

PAPAX Mutual Fund (Princeton Adaptive Premium Fund Class A) is managed by Princeton Adaptive Premium Fund with $117.85 in net assets. PAPAX expense ratio is 2.00%, holding 36 positions across sectors including Financials. Inception date: 2022-09-23.

PAPAX performance shows a YTD return of 1.97%. The 1-year return is 4.67%. PAPAX dividend yield stands at 6.03%, paid quarterly.

PAPAX top holdings include B 2/3/26 Govt (10.1%), Treasury Bill Apr 14, 2026 (8.9%), Treasury Bill Feb 24, 2026 2026-02-24 (8.7%), Treasury Bill 0% Feb 10, 2026 (8.4%), Treasury Bill 0% Mar 03, 2026 (8.4%). Go to all PAPAX holdings, PAPAX sectors, or PAPAX dividends.

PAPAX can be compared against other funds. Use PAPAX overlap to find shared positions, or PAPAX vs another fund for a side-by-side view. PAPAX alternatives are available via the screener, along with tax-loss harvesting opportunities.